MRNA logo

MRNA
Moderna Inc

110,174
Mkt Cap
$11.69B
Volume
30,946.00
52W High
$48.92
52W Low
$22.28
PE Ratio
-3.71
MRNA Fundamentals
Price
$29.92
Prev Close
$29.46
Open
$29.28
50D MA
$26.14
Beta
1.28
Avg. Volume
10.59M
EPS (Annual)
-$9.27
P/B
1.25
Rev/Employee
$557,931.03
Loading...
Loading...
News
all
press releases
Top Biotech Stocks Worth Watching - December 13th
Danaher, Vertex Pharmaceuticals, Moderna, United Therapeutics, argenex, Abivax, and WAVE Life Sciences are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Promising Biotech Stocks To Watch Now - December 14th
Danaher, Vertex Pharmaceuticals, Moderna, United Therapeutics, and argenex are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...
MarketBeat·2d ago
News Placeholder
Top Biotech Stocks To Add to Your Watchlist - December 12th
Danaher, Vertex Pharmaceuticals, United Therapeutics, Moderna, Abivax, argenex, and Celcuity are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks...
MarketBeat·3d ago
News Placeholder
Banque Transatlantique SA Cuts Position in Moderna, Inc. $MRNA
Banque Transatlantique SA trimmed its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 73.5% in the second quarter, according to its most recent disclosure with the Securities and...
MarketBeat·3d ago
News Placeholder
Bellevue Group AG Has $34.18 Million Stock Position in Moderna, Inc. $MRNA
Bellevue Group AG lessened its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 18.4% in the second quarter, according to its most recent filing with the SEC. The firm owned...
MarketBeat·3d ago
News Placeholder
Moderna (NASDAQ:MRNA) Director Sells $13,910.40 in Stock
Moderna, Inc. (NASDAQ:MRNA - Get Free Report) Director Abbas Hussain sold 504 shares of the company's stock in a transaction on Tuesday, December 9th. The shares were sold at an average price of...
MarketBeat·4d ago
News Placeholder
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance PR Newswire VANCOUVER, BC, Dec. 12, 2025 Issued on behalf...
PR Newswire·4d ago
News Placeholder
Moderna (NASDAQ:MRNA) Director Abbas Hussain Sells 504 Shares
Moderna, Inc. (NASDAQ:MRNA - Get Free Report) Director Abbas Hussain sold 504 shares of the firm's stock in a transaction dated Tuesday, December 9th. The shares were sold at an average price of...
MarketBeat·4d ago
News Placeholder
Moderna (MRNA) Q4 2024 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·5d ago
News Placeholder
Is the Market Bullish or Bearish on Moderna Inc?
read more...
Benzinga·5d ago
<
1
2
...
>

Latest MRNA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.